Karen Wagner

Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, United States of America

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Psychiatry > Mood Disorders (since 14 November 2005)

All recent recommendations

• 6.0
  Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome.
  Recommended by Karen Wagner
  
• 3.0
  Project Ice Storm: prenatal maternal stress affects cognitive and linguistic functioning in 5 1/2-year-old children.
  Recommended by Karen Wagner
  
• 4.8
  Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
  Recommended by Karen Wagner, Stefano Pallanti with Silvia Bernardi
  
• 4.8
  Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
  Recommended by Robert Findling, Karen Wagner
  
• 3.0
  Treatment of early-onset schizophrenia spectrum disorders (TEOSS): demographic and clinical characteristics.
  Recommended by Karen Wagner
  
• 6.0
  Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
  Recommended by Karen Wagner
  
• 6.4
  Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
  Recommended by Robert Findling, Karen Wagner
  
• 6.0
  Offspring of depressed parents: 20 years later.
  Recommended by Karen Wagner